project id: TCGA-PAAD; case submitter id: TCGA-RB-A7B8; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.17; rna integrity number: 7.3; age at index: 81; days to birth: -29585; days to death: 466; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1932; age at diagnosis: 29585; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 36.0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Head of pancreas; synchronous malignancy: No; tissue or organ of origin: Head of pancreas; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to collection: 84; days to sample procurement: 0; initial weight: 320.0; portion submitter id: TCGA-RB-A7B8-01A-12; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 50.0; percent stromal cells: 30.0; percent tumor cells: 20.0; percent tumor nuclei: 25.0;